Q4 2024 |
9 |
$18.1M |
+$379K |
-$37.6M |
-$37.3M |
ESTA, MSOS, LUNG, QTRX, OCX
|
13F-HR |
2/12/2025, 01:42 PM |
Q3 2024 |
18 |
$60.8M |
+$6.86M |
-$35.6M |
-$28.7M |
MSOS, ESTA, GKOS, NTRA, ISRG
|
13F-HR |
11/14/2024, 12:12 PM |
Q2 2024 |
27 |
$82.7M |
+$19.4M |
-$75.5M |
-$56.2M |
ESTA, GKOS, ISRG, NTRA, MSOS
|
13F-HR |
8/14/2024, 09:31 AM |
Q1 2024 |
31 |
$141M |
+$79M |
-$33.8M |
+$45.3M |
EXAS, ESTA, ISRG, QTRX, LYRA
|
13F-HR |
5/15/2024, 11:59 AM |
Q4 2023 |
53 |
$328M |
+$17.9M |
-$111M |
-$93.3M |
QTRX, ESTA, LYRA, LIVN, LUNG
|
13F-HR |
2/13/2024, 09:46 AM |
Q3 2023 |
115 |
$518M |
+$190M |
-$349M |
-$159M |
ESTA, QTRX, GKOS, LIVN, NTRA
|
13F-HR |
11/14/2023, 11:54 AM |
Q2 2023 |
125 |
$755M |
+$534M |
-$718M |
-$184M |
ESTA, QTRX, GKOS, CUTR, INSP
|
13F-HR |
8/14/2023, 11:51 AM |
Q1 2023 |
71 |
$912M |
+$633M |
-$83.6M |
+$550M |
ESTA, VRAYQ, CUTR, GKOS, QTRX
|
13F-HR |
5/15/2023, 11:44 AM |
Q4 2022 |
193 |
$1.94B |
+$667M |
-$217M |
+$449M |
ESTA, VRAYQ, INSP, CUTR, GKOS
|
13F-HR |
2/14/2023, 11:00 AM |
Q3 2022 |
194 |
$1.72B |
+$610M |
-$287M |
+$324M |
ESTA, VRAYQ, CUTR, GKOS, INSP
|
13F-HR |
11/14/2022, 03:13 PM |
Q2 2022 |
200 |
$1.72B |
+$650M |
-$368M |
+$282M |
ESTA, CUTR, INSP, VRAYQ, GKOS
|
13F-HR |
8/15/2022, 04:35 PM |
Q1 2022 |
222 |
$3.08B |
+$1.34B |
-$288M |
+$1.05B |
CUTR, ESTA, VRAYQ, INSP, NSTG
|
13F-HR |
5/16/2022, 04:58 PM |
Q4 2021 |
230 |
$2.76B |
+$830M |
-$436M |
+$393M |
VRAYQ, ESTA, NSTG, INSP, CUTR
|
13F-HR |
2/14/2022, 03:34 PM |
Q3 2021 |
161 |
$1.33B |
+$424M |
-$351M |
+$73.5M |
VRAYQ, ESTA, NSTGQ, LIVN, INSP
|
13F-HR |
11/15/2021, 04:44 PM |
Q2 2021 |
145 |
$1.4B |
+$283M |
-$413M |
-$130M |
ESTA, OCX, VRAYQ, NSTGQ, INOV
|
13F-HR |
8/16/2021, 11:23 AM |
Q1 2021 |
150 |
$1.45B |
+$440M |
-$260M |
+$180M |
ESTA, NSTGQ, OCX, INOV, INSP
|
13F-HR |
5/12/2021, 03:10 PM |
Q4 2020 |
177 |
$2.75B |
+$1.02B |
-$903M |
+$118M |
QQQ, SPY, IWM, XBI, NSTG
|
13F-HR |
2/16/2021, 02:09 PM |
Q3 2020 |
152 |
$1.94B |
+$1.11B |
-$162M |
+$943M |
SPY, IWM, XBI, QQQ, XLV
|
13F-HR |
11/16/2020, 11:28 AM |
Q2 2020 |
121 |
$1.04B |
+$386M |
-$199M |
+$188M |
IWM, SPY, IHI, XLV, XBI
|
Restatement |
2/12/2021, 09:04 AM |
Q1 2020 |
92 |
$842M |
+$339M |
-$82.8M |
+$256M |
SPY, XLV, XBI, MDT, IWM
|
Restatement |
2/12/2021, 09:00 AM |
Q4 2019 |
100 |
$1.14B |
+$684M |
-$29.2M |
+$655M |
SPY, IWM, XLV, XBI, ABMD
|
Restatement |
2/12/2021, 09:08 AM |
Q3 2019 |
90 |
$585M |
+$304M |
-$37.5M |
+$267M |
XLV, INSP, AMGN, IWM, NSTG
|
Restatement |
2/12/2021, 09:06 AM |
Q2 2019 |
98 |
$658M |
+$260M |
-$130M |
+$130M |
SPY, IWM, INSP, IHI, NSTG
|
Restatement |
2/12/2021, 09:02 AM |
Q1 2019 |
103 |
$703M |
+$333M |
-$81.8M |
+$251M |
SPY, IWM, FXH, ZBH, INSP
|
Restatement |
2/12/2021, 08:59 AM |
Q4 2018 |
74 |
$501M |
+$285M |
-$22.5M |
+$263M |
SPY, IWM, MDT, FXH, INSP
|
Restatement |
2/11/2021, 02:18 PM |
Q3 2018 |
106 |
$475M |
+$327M |
-$19M |
+$308M |
SPY, IWM, LIVN, XLV, ICUI
|
Restatement |
2/11/2021, 02:14 PM |
Q2 2018 |
91 |
$249M |
+$181M |
-$45.8M |
+$136M |
LIVN, ATHN, ICUI, XBI, IWM
|
Restatement |
2/11/2021, 02:09 PM |
Q1 2018 |
66 |
$169M |
+$88.4M |
-$22M |
+$66.4M |
XLV, MRK, ICUI, GMED, LIVN
|
Restatement |
2/11/2021, 02:04 PM |
Q4 2017 |
69 |
$239M |
+$128M |
-$51.1M |
+$77.2M |
OSIS, LIVN, FXH, XLV, ICUI
|
Restatement |
2/11/2021, 01:59 PM |
Q3 2017 |
76 |
$342M |
+$219M |
-$25.6M |
+$193M |
SPY, PFE, BSX, LIVN, ICUI
|
Restatement |
2/11/2021, 01:55 PM |
Q2 2017 |
68 |
$252M |
+$138M |
-$43.8M |
+$94.4M |
EVHC, BSX, ESRX, ALXN, LH
|
13F-HR |
8/14/2017, 10:09 AM |
Q1 2017 |
78 |
$338M |
+$188M |
-$33M |
+$155M |
SPY, HOLX, BIO, BAX, BCR
|
13F-HR |
5/15/2017, 09:18 AM |
Q4 2016 |
67 |
$273M |
+$188M |
-$27.7M |
+$160M |
SPY, XLV, UNH, ATHN, ABBV
|
13F-HR |
2/14/2017, 08:23 AM |
Q3 2016 |
86 |
$329M |
+$181M |
-$12.1M |
+$169M |
HCA, SYK, AGN, FXH, NXTM
|
13F-HR |
11/14/2016, 08:17 AM |
Q2 2016 |
74 |
$235M |
+$90.5M |
-$34.3M |
+$56.2M |
AGN, AET, CNC, FXH, MDT
|
13F-HR |
8/15/2016, 09:29 AM |
Q1 2016 |
77 |
$220M |
+$115M |
-$21.5M |
+$93.4M |
AGN, AGN, BAX, UHS, ABBV
|
13F-HR |
5/16/2016, 08:38 AM |
Q4 2015 |
75 |
$237M |
+$134M |
-$21M |
+$113M |
AZN, CIXXXX, BAX, TFX, PODD
|
13F-HR |
2/16/2016, 08:19 AM |
Q3 2015 |
66 |
$175M |
+$63.4M |
-$10.6M |
+$52.7M |
CIXXXX, UHS, TFX, SYK, BSX
|
13F-HR |
11/16/2015, 12:31 PM |
Q2 2015 |
64 |
$186M |
+$96.4M |
-$20M |
+$76.4M |
CIXXXX, UHS, TFX, TFX, ALIM
|
13F-HR |
8/14/2015, 10:05 AM |
Q1 2015 |
63 |
$194M |
+$124M |
-$13.8M |
+$110M |
BAX, BAX, BSX, ABT, STJ
|
13F-HR |
5/14/2015, 09:31 AM |
Q4 2014 |
70 |
$270M |
|
|
|
ILMN, SYK, ISRG, EW, RMD
|
13F-HR |
2/17/2015, 09:00 AM |